Literature DB >> 15893695

Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.

Kohsuke Imai1, Yi Zhu, Patrick Revy, Tomohiro Morio, Shuki Mizutani, Alain Fischer, Shigeaki Nonoyama, Anne Durandy.   

Abstract

Autosomal recessive form of hyper-IgM syndrome type 2 (AR-HIGM2) is secondary to mutations affecting both alleles of AICDA gene encoding activation-induced cytidine deaminase, characterized by defects of immunoglobulin class switch recombination (CSR) and somatic hypermutation (SHM) in most of the patients. We herein report the immunological phenotype of seven patients carrying a single heterozygous R190X mutation in AICDA. Variable defect in in vivo CSR inherited as an autosomal dominant (AD) trait strongly suggests that this heterozygous AICDA mutation causes HIGM (AD-HIGM2). In AD-HIGM2 B cells, CSR was consistently found impaired in vitro. However, in contrast to AR-HIGM2, the CSR-induced double-stranded DNA breaks in the switch region of IgM heavy chain gene were detected. The SHM frequency in V regions of IgM heavy chain gene in B cells was normal in all (but one patient). The characteristics of the AD-HIGM2 phenotype indicate that the AID C-terminal region may be involved in DNA repair machinery required for CSR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893695     DOI: 10.1016/j.clim.2005.02.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  37 in total

1.  Immunodeficiencies due to defects of class-switch recombination.

Authors:  Luigi D Notarangelo; Gaetana Lanzi; Paola Toniati; Silvia Giliani
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 2.  Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair.

Authors:  Mala Samaranayake; Janusz M Bujnicki; Michael Carpenter; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

Review 3.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

Review 4.  Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature.

Authors:  Neslihan Edeer Karaca; Anne Durandy; Nesrin Gulez; Guzide Aksu; Necil Kutukculer
Journal:  Eur J Pediatr       Date:  2011-01-28       Impact factor: 3.183

Review 5.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

6.  APOBEC3B and AID have similar nuclear import mechanisms.

Authors:  Lela Lackey; Zachary L Demorest; Allison M Land; Judd F Hultquist; William L Brown; Reuben S Harris
Journal:  J Mol Biol       Date:  2012-03-23       Impact factor: 5.469

Review 7.  Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.

Authors:  Xiangxue Meng; Bin Yang; Wen-Chen Suen
Journal:  Innate Immun       Date:  2017-11-13       Impact factor: 2.680

8.  Overlapping activation-induced cytidine deaminase hotspot motifs in Ig class-switch recombination.

Authors:  Li Han; Shahnaz Masani; Kefei Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

9.  The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence.

Authors:  Roland Geisberger; Cristina Rada; Michael S Neuberger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

Review 10.  Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.

Authors:  Anne Durandy; Tineke Cantaert; Sven Kracker; Eric Meffre
Journal:  Autoimmunity       Date:  2013-01-10       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.